FDA Approved: TACROLIMUS — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmaceuticals Inc.’s supplemental application for tacrolimus, approving a generic tacrolimus product under an Abbreviated New Dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)